Methods of using and compositions comprising PDE4 modulators for treatment, prevention and management of tuberculosis

Details for Australian Patent Application No. 2010213936 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.; Kaplan, Gilla

Agent Henry Hughes Patent & Trade Mark Attorneys

Pub. Number AU-A-2010213936

PCT Pub. Number WO2010/093588

Priority 61/151,467 10.02.09 US

Filing date 9 February 2010

Wipo publication date 19 August 2010

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4035 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/70 (2006.01) - Carbohydrates

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/093588 Priority application(s): WO2010/093588

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010213941-Automated intraocular lens injector device

2010213932-Intermediate vapor collection within encapsulated control infrastructures